Skip to content


Dexilant, Dexilant Solutab (dexlansoprazole) is a small molecule pharmaceutical. Dexlansoprazole was first approved as Dexilant on 2009-01-30. It is used to treat gastroesophageal reflux, heartburn, and peptic esophagitis in the USA. Dexilant's patents are valid until 2032-03-05 (FDA).
Trade Name Dexilant, Dexilant Solutab
Common Name Dexlansoprazole
Indication gastroesophageal reflux, heartburn, peptic esophagitis
Drug Class Antiulcer agents (benzimidazole derivatives)
Get full access now